AsiaIPEX is a one-stop-shop for players in the IP industry, facilitating IP trade and connection to the IP world. Whether you are a patent owner interested in selling your IP, or a manufacturer looking to buy technologies to upgrade your operation, you will find the portal a useful resource.

Back to search results

Drug Delivery Vehicle for Treatment of Eye Disease: Glaucoma

Detailed Technology Description

Human carbonic anhydrase (hCAII) is a metalloenzyme that catalyzes the reversible hydration of carbon dioxide to bicarbonate and is associated with glaucoma (a major cause of blindness).Carboxybenzenesulfonamide, an inhibitor of the hCAII enzyme, is attached to nanoceria particles using epichlorohydrin as an intermediate linkage. Along with the CA inhibitor, a fluorophore (carboxyfluorescein) is also attached on the nanoparticles to enable the tracking of the nanoparticles in vitro as well as in vivo.X-ray photoelectron spectroscopic studies carried out at each reaction step confirmed the successful derivatization of the nanoceria particles. The attachment of carboxyfluorescein was also confirmed by confocal fluorescence microscopy.

Industry

Biomedical

Sub Group

Medical Composition

Country/Region

USA

For more information, please click Here